Consumer and Drug Industry Representatives Back New Fees to Cover Foreign Inspections

Wednesday, March 16, 2011 Drug News
Email Print This Page Comment bookmark
Font : A-A+

WASHINGTONAllan Coukell, director of the Medical Safety Division of the Pew Health Group, issued the following statement

today, commenting on a March 14-15 conference, "After Heparin: A Roundtable on Ensuring the Safety of the U.S. Drug Supply," in which industry and consumer experts called for changes to address the risk of counterfeit and
substandard medicine:

"Americans now consume pharmaceuticals that are produced in thousands of manufacturing facilities all over the world, many in developing nations where FDA has limited ability to ensure compliance with quality standards. Although incidences of adulterated and counterfeit drugs in the U.S. are low, the impact of these events can be tragic, as we saw with contaminated heparin in 2008. That is why the Pew Health Group brought together representatives of the entire pharmaceutical supply chain, from drug ingredient manufacturers to pharmacists who interact with patients. 

"During day one of the Pew conference on imported drug safety, representatives from manufacturing and consumer groups agreed to back new industry fees to cover foreign inspections. This call to action is a good start.

"Now Congress must act to give FDA much needed resources and oversight powers, including the authority to order a drug recall. Lawmakers also must take steps to ensure that pharmaceutical companies are adequately validating the quality of their suppliers—wherever they are located.

"Systemic improvement is never easy. But with a coalition like the one assembled at this conference, reform is possible."

Pew Health Group

The Pew Health Group is the health and consumer-product safety arm of The Pew Charitable Trusts, a nonprofit organization that applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. www.pewtrusts.org/health.

CONTACT: Linda Paris, Pew Health Group, +1-202-540-6354 or [email protected]

/PRNewswire-USNewswire -- March 15, 2011/

SOURCE Pew Health Group



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store